Advertisement
For patients with COVID-19

Anosmia in COVID-19 Linked to Lower Risk for Admission

0
Pulmonary infiltrates and/or pleural effusion on chest radiograph may increase risk for admission
In a cohort of hospitalized adults with COVID-19

Black Patients Overrepresented in Hospitalized COVID-19 Cohort

0
Black patients not more likely to receive invasive mechanical ventilation, die during hospitalization
In 2019

Incidence of Enteric Infections Due to Pathogens Up or Stable

0
Compared with 2016 to 2018, incidence in 2019 was increased for infections caused by five pathogens

April 2020 Briefing – Emergency Medicine

0
Here are what the editors at HealthDay consider to be the most important developments in Emergency Medicine for April 2020. This roundup includes the...
The U.S. Food and Drug Administration has granted an emergency use authorization for remdesivir to treat hospitalized patients with suspected or confirmed COVID-19

FDA Issues Emergency Use Authorization for Remdesivir

0
Remdesivir can be administered intravenously to treat COVID-19 patients with severe disease
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 27 to May 1

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Screening symptomatic health care workers for severe acute respiratory syndrome coronavirus 2 infection is feasible during the pandemic

Symptomatic Health Care Staff in U.K. Screened for COVID-19

0
Shift in transmission dynamics noted as of March 24, concurrent with steps to implement social distancing
Remdesivir may speed time to clinical improvement for patients with severe acute respiratory syndrome coronavirus 2 infection

Remdesivir May Accelerate Recovery From Severe COVID-19

0
Early results from NIH study promising, but Lancet study did not show significant clinical benefit
Mildly symptomatic patients with severe acute respiratory syndrome coronavirus 2 infection often have alterations in smell or taste

Rate, Timing of Altered Smell, Taste in Mild COVID-19 Examined

0
Overall, 64.4 percent of patients reported altered sense of smell, taste; one-third also had blocked nose
For adult emergency department patients with syncope

NT-proBNP Does Not Improve Evaluation of Syncope in the ED

0
Serum NT-proBNP concentrations were generally higher in patients with 30-day serious adverse events